Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ) has shared an update.
Lumos Diagnostics, a leader in rapid point-of-care diagnostic technologies, has announced a change in its registered office and principal place of business to a new address in Melbourne, Australia. This move is part of the company’s ongoing efforts to streamline its operations and enhance its market presence, with all other contact details remaining unchanged.
More about Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics specializes in rapid, cost-effective, and complete point-of-care diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. The company offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms, and it develops, manufactures, and commercializes novel Lumos-branded POC tests targeting infectious and inflammatory diseases.
Average Trading Volume: 1,206,855
Technical Sentiment Signal: Sell
Current Market Cap: A$20.96M
For detailed information about LDX stock, go to TipRanks’ Stock Analysis page.